Every story in this section, newest first — page 264 of 373.
Cohen & Company (NYSE:COHN) capped a transformative fiscal year with a massive top-line expansion, fueled by a 246% year-over-year revenue increase that prompted the board to reward shareholders with both a quarterly and a special dividend.
Mammoth Energy Services (NASDAQ:TUSK) capped off a year of aggressive restructuring, reporting full-year 2025 results that highlight a dramatic shift from traditional oilfield services toward a specialized aviation and rental platform.
The U.S. government has begun denying requests from companies seeking refunds for billions of dollars in illegal tariffs, despite a landmark Supreme Court ruling that struck down the levies last month.
Immuneering (NASDAQ:IMRX) has achieved a 64% overall survival rate at 12 months in an ongoing Phase 2a clinical trial for its lead drug candidate, atebimetinib, in combination with chemotherapy for patients with metastatic pancreatic cancer.
Jade Biosciences (NASDAQ:JBIO) reported fourth-quarter and full-year 2025 financial results on Friday, highlighting a robust cash position and a clear clinical roadmap for its portfolio of monoclonal antibodies.
AtaiBeckley (NASDAQ:ATAI) reported fourth-quarter and full-year 2025 results on Friday, marking its first annual report since the transformative merger of atai Life Sciences and Beckley Psytech.
Genesco (NYSE:GCO) reported fourth-quarter and full-year fiscal 2026 results on Friday that significantly outpaced the prior year, driven by a powerful holiday performance at its Journeys and Johnston & Murphy banners.
Embraer (NYSE:EMBJ) reported fourth-quarter and full-year 2025 results on Friday that significantly outpaced Wall Street projections, fueled by a year-end surge in aircraft deliveries and expanding margins.
Bluejay Diagnostics (NASDAQ:BJDX) issued a corporate update on Friday detailing its 2026 operational roadmap, focused on the regulatory path for its Symphony™ System and its flagship IL-6 clinical test.
Algonquin Power & Utilities (NYSE:AQN) reported a significant financial turnaround for fiscal 2025 on Friday, transitioning from a prior-year loss to a net profit of $208 million.
MarketWise (NASDAQ:MKTW) reported fourth-quarter and full-year 2025 results on Friday, highlighting a successful pivot toward higher-value products that drove billings and cash flow well above company guidance.
Cango (NYSE:CANG) announced a strategic shift in its operational focus on Friday, detailing plans to transform from a dedicated Bitcoin miner into an integrated energy and artificial intelligence compute platform.
SFL Corporation (NYSE:SFL) reached an agreement to deploy one of the industry's most specialized offshore assets to the Canadian market, locking in a significant revenue backlog through 2028.
Embraer (NYSE:EMBJ) issued a bullish financial and operational outlook for 2026 on Friday, projecting significant growth in aircraft deliveries and profitability as it capitalizes on a record $31.3 billion backlog.
CLPS Incorporation (NASDAQ:CLPS) reported unaudited financial results for the first half of fiscal 2026 on Friday, highlighting a successful strategic pivot toward international markets and high-demand technologies.
Pfizer (NYSE:PFE) significantly expanded its metabolic footprint on Friday, announcing that Chinese regulators have approved its GLP-1 receptor agonist, Xianweiying (ecnoglutide), for long-term weight management in overweight and obese adults.
The AES Corp. (NYSE:AES) reported fourth-quarter and full-year 2025 results on Friday, significantly exceeding Wall Street’s bottom-line projections even as the company prepares to go private.
Nutex Health (NASDAQ:NUTX) reported fourth-quarter and full-year 2025 results on Thursday, headlined by a massive leap in annual revenue and a new $25 million share repurchase program.
Quipt Home Medical (NASDAQ:QIPT) reached a definitive milestone in its transition to a private entity on Thursday, receiving a final order from the Supreme Court of British Columbia approving its previously announced plan of arrangement.
The conflict with Iran has escalated into a global crisis following the sinking of the IRIS Dena frigate near Sri Lanka by a US submarine.
Costco Wholesale (NASDAQ:COST) reported fiscal second-quarter financial results on Thursday that surpassed Wall Street expectations, driven by resilient consumer spending and robust membership growth.
CorMedix (NASDAQ:CRMD) reported a significant return to profitability for the fourth quarter on Thursday, as the commercial rollout of its lead product, DefenCath, gained momentum alongside contributions from its newly acquired Melinta Therapeutics portfolio.
PagBank (NYSE:PAGS) posted a recurring net income of R$ 678 million for the fourth quarter of 2025, supported by a double-digit increase in deposits and an accelerating credit business.
Tuniu (NASDAQ:TOUR) achieved a return to profitability in the final quarter of 2025, driven by a resurgence in high-margin packaged tours and a leaner operational structure.
